The FDA has cleared Auvelity (dextromethorphan/bupropion) for the treatment of major depressive disorder (MDD) in adults, setting up a launch in the fourth quarter of this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback